On November 20, Synopsys fell 3.23% in Regular Trading, trading at $416.48 per share, with turnover of $189 million.
The latest market discussion pointed to renewed debate over whether the company’s valuation is fully supported by cash-flow expectations, which offset the positive sentiment created a day earlier by Barclays initiating coverage with an Overweight rating and a $640 price target.
Background context remains constructive: recent analyst target increases included $615 from Rothschild & Co Redburn, $620 from Needham, $605 from KeyBanc, and $574 from Morgan Stanley. Company-specific developments disclosed earlier also included a more than $1 billion strategic IP agreement with Amazon, a $1 billion accelerated share repurchase plan, and fiscal 2027 targets calling for about $11.15 billion in revenue at the midpoint.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)